RhumbLine Advisers’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.21M | Buy |
41,745
+1,371
| +3% | +$107K | ﹤0.01% | 1617 |
|
|
2025
Q4 | $3.19M | Sell |
40,374
-2,074
| -5% | -$180K | ﹤0.01% | 1632 |
|
|
2025
Q3 | $3.89M | Buy |
42,448
+467
| +1% | +$38.1K | ﹤0.01% | 1561 |
|
|
2025
Q2 | $2.74M | Buy |
41,981
+658
| +2% | +$42.8K | ﹤0.01% | 1712 |
|
|
2025
Q1 | $2.77M | Sell |
41,323
-684
| -2% | -$40.9K | ﹤0.01% | 1649 |
|
|
2024
Q4 | $2.32M | Sell |
42,007
-203
| -0.5% | -$11.7K | ﹤0.01% | 1808 |
|
|
2024
Q3 | $2.52M | Buy |
42,210
+40
| +0.1% | +$2.44K | ﹤0.01% | 1783 |
|
|
2024
Q2 | $2.69M | Buy |
42,170
+5,617
| +15% | +$365K | ﹤0.01% | 1729 |
|
|
2024
Q1 | $2.53M | Sell |
36,553
-1,396
| -4% | -$84.3K | ﹤0.01% | 1786 |
|
|
2023
Q4 | $2.09M | Sell |
37,949
-1,735
| -4% | -$95.5K | ﹤0.01% | 1878 |
|
|
2023
Q3 | $2.3M | Buy |
39,684
+4,700
| +13% | +$271K | ﹤0.01% | 1786 |
|
|
2023
Q2 | $1.88M | Buy |
34,984
+999
| +3% | +$44.3K | ﹤0.01% | 1940 |
|
|
2023
Q1 | $1.35M | Buy |
33,985
+2,382
| +8% | +$100K | ﹤0.01% | 2004 |
|
|
2022
Q4 | $1.27M | Buy |
31,603
+926
| +3% | +$34.8K | ﹤0.01% | 2018 |
|
|
2022
Q3 | $986K | Buy |
30,677
+482
| +2% | +$16.5K | ﹤0.01% | 2136 |
|
|
2022
Q2 | $896K | Buy |
30,195
+4,279
| +17% | +$123K | ﹤0.01% | 2199 |
|
|
2022
Q1 | $728K | Buy |
25,916
+1,096
| +4% | +$40.9K | ﹤0.01% | 2263 |
|
|
2021
Q4 | $1.14M | Sell |
24,820
-6,369
| -20% | -$274K | ﹤0.01% | 2152 |
|
|
2021
Q3 | $1.02M | Sell |
31,189
-3,257
| -9% | -$101K | ﹤0.01% | 2219 |
|
|
2021
Q2 | $1.21M | Sell |
34,446
-378
| -1% | -$12.9K | ﹤0.01% | 2155 |
|
|
2021
Q1 | $1.26M | Buy |
34,824
+1,150
| +3% | +$36K | ﹤0.01% | 2103 |
|
|
2020
Q4 | $978K | Buy |
33,674
+3,239
| +11% | +$92.8K | ﹤0.01% | 2139 |
|
|
2020
Q3 | $859K | Sell |
30,435
-1,363
| -4% | -$40.6K | ﹤0.01% | 2050 |
|
|
2020
Q2 | $1.03M | Buy |
31,798
+98
| +0.3% | +$3.51K | ﹤0.01% | 2029 |
|
|
2020
Q1 | $1.29M | Buy |
31,700
+746
| +2% | +$39.7K | ﹤0.01% | 1767 |
|
|
2019
Q4 | $1.91M | Buy |
30,954
+2,217
| +8% | +$147K | ﹤0.01% | 1814 |
|
|
2019
Q3 | $2.09M | Buy |
28,737
+2,221
| +8% | +$166K | ﹤0.01% | 1722 |
|
|
2019
Q2 | $2.18M | Buy |
26,516
+2,436
| +10% | +$173K | ﹤0.01% | 1690 |
|
|
2019
Q1 | $1.7M | Sell |
24,080
-259
| -1% | -$15.2K | ﹤0.01% | 1807 |
|
|
2018
Q4 | $1.1M | Buy |
24,339
+3,642
| +18% | +$191K | ﹤0.01% | 1957 |
|
|
2018
Q3 | $1.17M | Sell |
20,697
-1,169
| -5% | -$71.5K | ﹤0.01% | 1933 |
|
|
2018
Q2 | $1.46M | Buy |
21,866
+1,399
| +7% | +$87.3K | ﹤0.01% | 1839 |
|
|
2018
Q1 | $1.19M | Buy |
20,467
+678
| +3% | +$43K | ﹤0.01% | 1861 |
|
|
2017
Q4 | $1.27M | Buy |
19,789
+2,807
| +17% | +$175K | ﹤0.01% | 1843 |
|
|
2017
Q3 | $891K | Buy |
16,982
+990
| +6% | +$47.2K | ﹤0.01% | 2030 |
|
|
2017
Q2 | $748K | Sell |
15,992
-81
| -0.5% | -$3.91K | ﹤0.01% | 2104 |
|
|
2017
Q1 | $796K | Buy |
16,073
+3,725
| +30% | +$209K | ﹤0.01% | 2027 |
|
|
2016
Q4 | $749K | Buy |
12,348
+1,288
| +12% | +$78.8K | ﹤0.01% | 2006 |
|
|
2016
Q3 | $734K | Buy |
11,060
+980
| +10% | +$61.3K | ﹤0.01% | 1987 |
|
|
2016
Q2 | $563K | Buy |
10,080
+194
| +2% | +$9.43K | ﹤0.01% | 2125 |
|
|
2016
Q1 | $333K | Buy |
9,886
+100
| +1% | +$3.39K | ﹤0.01% | 2475 |
|
|
2015
Q4 | $442K | Buy |
9,786
+670
| +7% | +$28.8K | ﹤0.01% | 2316 |
|
|
2015
Q3 | $360K | Buy |
9,116
+196
| +2% | +$11.2K | ﹤0.01% | 2437 |
|
|
2015
Q2 | $553K | Buy |
8,920
+10
| +0.1% | +$595 | ﹤0.01% | 2258 |
|
|
2015
Q1 | $557K | Buy |
8,910
+2,200
| +33% | +$134K | ﹤0.01% | 2236 |
|
|
2014
Q4 | $378K | Buy |
+6,710
| New | +$296K | ﹤0.01% | 2442 |
|
Other funds holding ANIP
VCM
SCM
TCM
GAM
DTC
